MapMyGenome Acquires Microbiome Insights to Expand Global Health Genomics Play

The acquisition boosts MapMyGenome’s offerings in metagenomics, transcriptomics, and targeted metabolomics, with plans to roll out integrated genomics and microbiome testing services across North America.

Hyderabad-based genomics and microbiome testing firm MapMyGenome has acquired Canada’s Microbiome Insights, a global leader in microbial sequencing, marking its formal entry into the North American market and strengthening its international clinical and research capabilities.

The deal includes Microbiome Insights’ CAP-accredited lab in Canada and its intellectual property portfolio. The acquisition boosts MapMyGenome’s offerings in metagenomics, transcriptomics, and targeted metabolomics, with plans to roll out integrated genomics and microbiome testing services across North America.

Calling it a “major milestone,” MapMyGenome founder and CEO Anu Acharya said, “The human microbiome is pivotal to health, and this acquisition positions us as a leader in this area. It accelerates our North American footprint, aligning with our strategic vision of growth through targeted acquisitions leading up to our listing on the Indian market later this year.”

Microbiome Insights CEO Malcolm Kendall added, “Joining forces with MapMyGenome provides the resources and capabilities to offer higher quality services to our clients and accelerate growth.The combination of their expertise in AI-driven genomics solutions and our deep microbiome expertise will result in a new standard of cutting-edge services for clients worldwide.”

Stay tuned for more such updates on Digital Health News